SynthesisJournal of medical virology2022

Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis.

Zhiwei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.